Radiation therapy in renal cell carcinoma.
暂无分享,去创建一个
[1] I. Kaplan,et al. Pooled analysis of stereotactic ablative radiotherapy for primary renal cell carcinoma: A report from the International Radiosurgery Oncology Consortium for Kidney (IROCK) , 2018, Cancer.
[2] V. Tombolini,et al. Radiotherapy Controversies and Prospective in Head and Neck Cancer: A Literature-Based Critical Review , 2018, Neoplasia.
[3] B. Slotman,et al. Radiotherapy for renal cell carcinoma: renaissance of an overlooked approach , 2017, Nature Reviews Urology.
[4] B. Esmaeli,et al. Prognostic Value of the Staging System for Eyelid Tumors in the 7th Edition of the American Joint Committee on Cancer Staging Manual. , 2017, Ophthalmic plastic and reconstructive surgery.
[5] V. Tombolini,et al. New Approaches in Glioblastoma Multiforme: The Potential Role of Immune- check Point Inhibitors. , 2017, Current Cancer Drug Targets.
[6] N. Lawrentschuk,et al. Impact of stereotactic radiotherapy on kidney function in primary renal cell carcinoma: Establishing a dose-response relationship. , 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[7] H. Onishi,et al. Consensus statement Consensus statement from the International Radiosurgery Oncology Consortium for Kidney for primary renal cell carcinoma , 2016 .
[8] P. Brown,et al. Single-fraction versus multifraction spinal stereotactic radiosurgery for spinal metastases from renal cell carcinoma: secondary analysis of Phase I/II trials. , 2016, Journal of neurosurgery. Spine.
[9] E. Lam,et al. Local Control Rates of Metastatic Renal Cell Carcinoma (RCC) to Thoracic, Abdominal, and Soft Tissue Lesions Using Stereotactic Body Radiotherapy (SBRT) , 2015, Radiation oncology.
[10] M. Schluchter,et al. Phase I dose-escalation study of stereotactic body radiotherapy (SBRT) for poor surgical candidates with localized renal cell carcinoma. , 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[11] C. Marchetti,et al. Immunotherapy of Ovarian Cancer: The Role of Checkpoint Inhibitors , 2015, Journal of immunology research.
[12] M. Bader,et al. Single fraction radiosurgery for the treatment of renal tumors. , 2015, The Journal of urology.
[13] N. Corcoran,et al. Outcomes of stereotactic radiotherapy for cranial and extracranial metastatic renal cell carcinoma: A systematic review , 2015, Acta oncologica.
[14] M. Fehlings,et al. Spine stereotactic body radiotherapy for renal cell cancer spinal metastases: analysis of outcomes and risk of vertebral compression fracture. , 2014, Journal of neurosurgery. Spine.
[15] V. Khoo,et al. Radiotherapy for renal-cell carcinoma. , 2014, The Lancet. Oncology.
[16] R. Weichselbaum,et al. Stereotactic Body Radiotherapy for the Treatment of Oligometastatic Renal Cell Carcinoma , 2013, American journal of clinical oncology.
[17] I. Kaplan,et al. A Phase 1 Dose-Escalation Study of Robotic Radiosurgery in Inoperable Primary Renal Cell Carcinoma , 2013 .
[18] J. Mechalakos,et al. Tumor control outcomes after hypofractionated and single-dose stereotactic image-guided intensity-modulated radiotherapy for extracranial metastases from renal cell carcinoma. , 2012, International journal of radiation oncology, biology, physics.
[19] K. Rosenzweig,et al. Predictors of local control after single-dose stereotactic image-guided intensity-modulated radiotherapy for extracranial metastases. , 2011, International journal of radiation oncology, biology, physics.
[20] B. Kavanagh,et al. Stereotactic body radiation therapy for melanoma and renal cell carcinoma: impact of single fraction equivalent dose on local control , 2010, Radiation oncology.
[21] I. Kaplan,et al. Results of a Phase I Dose Escalation Study of Stereotactic Radiosurgery for Primary Renal Tumors , 2010 .
[22] M. Rafi,et al. Need for a new trial to evaluate postoperative radiotherapy in renal cell carcinoma: a meta-analysis of randomized controlled trials. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.
[23] M. Bilsky,et al. Risk of fracture after single fraction image-guided intensity-modulated radiation therapy to spinal metastases. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[24] S Richardson,et al. The treatment of primary and metastatic renal cell carcinoma (RCC) with image-guided stereotactic body radiation therapy (SBRT) , 2007, Biomedical imaging and intervention journal.
[25] G. Barnett,et al. Local control of brain metastases by stereotactic radiosurgery in relation to dose to the tumor margin. , 2006, Journal of neurosurgery.
[26] H. Blomgren,et al. A prospective Phase II trial of using extracranial stereotactic radiotherapy in primary and metastatic renal cell carcinoma , 2006, Acta oncologica.
[27] Sten Nilsson,et al. Extracranial stereotactic radiotherapy for primary and metastatic renal cell carcinoma. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[28] S. Campbell,et al. Metastatic renal cell carcinoma , 2003, Current treatment options in oncology.
[29] D. Kondziolka,et al. Stereotactic radiosurgery for brain metastasis from renal cell carcinoma , 1999, Cancer.
[30] A. Haimovitz-Friedman,et al. Ionizing radiation acts on cellular membranes to generate ceramide and initiate apoptosis , 1994, The Journal of experimental medicine.
[31] B. Werf-Messing,et al. Carcinoma of the kidney , 1973 .
[32] R. Finney. The value of radiotherapy in the treatment of hypernephroma--a clinical trial. , 1973, British journal of urology.
[33] P. Iversen,et al. A randomized trial of postoperative radiotherapy versus observation in stage II and III renal adenocarcinoma. A study by the Copenhagen Renal Cancer Study Group. , 1987, Scandinavian journal of urology and nephrology.
[34] O. Alfthan,et al. Preoperative irradiation in the treatment of renal adenocarcinoma. , 1977, Scandinavian journal of urology and nephrology.